Chronic use of benzodiazepines and psychomotor and cognitive test performance
dc.contributor.author | Lucki, Irwin | en_US |
dc.contributor.author | Geller, Andrew M. | en_US |
dc.contributor.author | Rickels, Karl | en_US |
dc.date.accessioned | 2006-09-11T17:47:02Z | |
dc.date.available | 2006-09-11T17:47:02Z | |
dc.date.issued | 1986-04 | en_US |
dc.identifier.citation | Lucki, Irwin; Rickels, Karl; Geller, Andrew M.; (1986). "Chronic use of benzodiazepines and psychomotor and cognitive test performance." Psychopharmacology 88(4): 426-433. <http://hdl.handle.net/2027.42/46439> | en_US |
dc.identifier.issn | 0033-3158 | en_US |
dc.identifier.issn | 1432-2072 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/46439 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2871579&dopt=citation | en_US |
dc.description.abstract | The performance of 43 long-term users (average = 5 years) of benzodiazepine (BZ) medications was examined on a battery of behavioral tasks, cognitive tests, and subjective mood rating scales. The performance of the chronic BZ users did not differ significantly from age- and sex-matched anxious subjects, except that critical flicker fusion (CFF) thresholds were lower and subjective ratings of tranquilization were higher in the BZ users. Twenty-two subjects were reexamined in order to determine the acute effects of BZ medications in long-term users. The acute administration of BZ medications significantly increased CFF thresholds, improved digit-symbol substitution test performance, impaired the delayed recall of verbal material, increased subjective ratings of tranquilization, and reduced physical sedation. Motor performance tests were not impaired and subjective feelings of sedation were not increased after the acute administration of BZs by chronic users. During withdrawal from long-term BZ use (17 subjects), CFF thresholds were elevated, subjective ratings of physical sedation and anxiety were increased, but performance on other psychomotor and cognitive tests was not altered. The results suggest that tolerance develops selectively to different behavioral and subjective effects of BZ medications with their continued use. Tolerance failed to develop to the antianxiety effects, the reduction of CFF threshold, and to the impairment of short-term memory caused by BZs. However, chronic users of BZ medications failed to demonstrate psychomotor-impairing or sedating effects to BZ medications. The results have implications for evaluating the safety of the long-term use of BZ medications. | en_US |
dc.format.extent | 1046954 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag | en_US |
dc.subject.other | Psychomotor Performance | en_US |
dc.subject.other | Psychiatry | en_US |
dc.subject.other | Biomedicine | en_US |
dc.subject.other | Pharmacology/Toxicology | en_US |
dc.subject.other | Benzodiazepines | en_US |
dc.subject.other | Chronic Drug Use | en_US |
dc.subject.other | Anxiety | en_US |
dc.subject.other | Memory | en_US |
dc.title | Chronic use of benzodiazepines and psychomotor and cognitive test performance | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Psychiatry, University of Pennsylvania School of Medicine, 19104, Philadelphia, PA, USA; Department of Psychology, University of Michigan, 48104, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Psychiatry, University of Pennsylvania School of Medicine, 19104, Philadelphia, PA, USA; Psychopharmacology Research and Treatment Clinic, 133 South 36th St. Room 402, 19104, Philadelphia, PA, USA | en_US |
dc.contributor.affiliationother | Department of Psychiatry, University of Pennsylvania School of Medicine, 19104, Philadelphia, PA, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 2871579 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/46439/1/213_2004_Article_BF00178503.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/BF00178503 | en_US |
dc.identifier.source | Psychopharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.